Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
0.5865
+0.0243 (4.32%)
Oct 23, 2026, 11:22 AM EDT - Market open
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of $162.52 million as of October 23, 2026. It is the 22,199th most valuable company in the world and the 3,769th biggest in the United States. Its market cap has decreased by 79.50% in one year.
Market Cap
162.52M
Enterprise Value
206.16M
1-Year Change
-79.50%
Global Rank
Country Rank
#3,769 United States
Category
ChartMarket Cap Chart
Since March 20, 2014, Akebia Therapeutics's market cap has decreased from $488.10M to $162.52M, a decrease of -66.70%. That is a compound annual growth rate of -8.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 162.52M | -61.96% |
| Dec 31, 2025 | 427.20M | 3.06% |
| Dec 31, 2024 | 414.50M | 77.44% |
| Dec 29, 2023 | 233.60M | 120.17% |
| Dec 30, 2022 | 106.10M | -73.17% |
| Dec 31, 2021 | 395.40M | -2.30% |
| Dec 31, 2020 | 404.70M | -46.16% |
| Dec 31, 2019 | 751.70M | 138.26% |
| Dec 31, 2018 | 315.50M | -55.11% |
| Dec 29, 2017 | 702.90M | 76.17% |
| Dec 30, 2016 | 399.00M | 0.81% |
| Dec 31, 2015 | 395.80M | 67.15% |
| Dec 31, 2014 | 236.80M | -51.49% |
| Mar 20, 2014 | 488.10M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioAge Labs | 254.96M |
| Lifecore Biomedical | 241.12M |
| SIGA Technologies | 226.33M |
| Glass House Brands | 218.64M |
| ADC Therapeutics | 194.05M |
| Journey Medical | 148.74M |
| Cardiol Therapeutics | 135.51M |
| Organigram Global | 133.84M |